| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8821525 | Clinical Imaging | 2018 | 4 Pages |
Abstract
Morphologic changes are seen in the majority of patients treated with cabozantinib, making Choi criteria valuable in response assessment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Atul B. Shinagare, Bhanusupriya Somarouthu, Hao Guo, Sara M. Tolaney, Nikhil H. Ramaiya,